Posted on 14/12/07
Big pharma shrinks as slowdown forces cuts
LONDON -- Big pharma is getting smaller.The decision yesterday by Novartis AG to cut 2,500 jobs highlights the accelerating pace of cost-cutting in a sector facing a worrying slowdown in growth, as research labs fail to deliver, generic competition bites and pressure on prices grows.
The full text of this article has 598 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
